According to an internal analysis, 29.6% of studies that are highly likely to fall under mandatory reporting requirements have no results information submitted to ClinicalTrials.gov.
Read More…FAST EU is directed to Facilitating and accelerating strategic clinical trials in the EU
Read More…Spain, France, Germany, Italy and Poland have access to the largest numbers of drug trials.
Read More…Ten Guiding Principles of Good AI Practice in Drug Development is mentioned in the guidance
Read More…According to the report EMA recommended 104 medicines in 2025 and 38 had a new active substance. Also 16 medicines were approved for rare diseases including the first drug for Wiscott-ALdrich syndrome.
Read More…